BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 25611961)

  • 1. The use of beta-blockers is associated with the occurrence of acute kidney injury in severe alcoholic hepatitis.
    Sersté T; Njimi H; Degré D; Deltenre P; Schreiber J; Lepida A; Trépo E; Gustot T; Moreno C
    Liver Int; 2015 Aug; 35(8):1974-82. PubMed ID: 25611961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of preoperative nonselective beta-blocker use on acute kidney injury after living donor liver transplantation: Propensity score analysis.
    Jeong HW; Kim JH; Han SB; Kwon HM; Jun IG; Song JG; Hwang GS
    Ann Hepatol; 2024; 29(4):101474. PubMed ID: 38331385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonselective beta-blockers may lead to stage 2 acute kidney injury and waitlist mortality in child class C cirrhosis.
    Lai M; Fenton C; Ge J; Rubin J; Lai JC; Cullaro G
    Hepatol Commun; 2023 Oct; 7(10):. PubMed ID: 37756037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characteristics and prognosis of hospitalized patients with moderate alcohol-associated hepatitis.
    Gaurnizo-Ortiz M; Nephew LD; Vilar-Gomez E; Kettler CD; Slaven JE; Ghabril MS; Desai AP; Orman ES; Chalasani N; Gawrieh S; Patidar KR
    Liver Int; 2024 Jan; 44(1):241-249. PubMed ID: 37904305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-selective beta-blockers are not associated with serious infections in veterans with cirrhosis.
    Bajaj JS; Ratliff SM; Heuman DM; Lapane KL
    Aliment Pharmacol Ther; 2013 Aug; 38(4):407-14. PubMed ID: 23786291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: A worldwide study.
    Arab JP; Díaz LA; Baeza N; Idalsoaga F; Fuentes-López E; Arnold J; Ramírez CA; Morales-Arraez D; Ventura-Cots M; Alvarado-Tapias E; Zhang W; Clark V; Simonetto D; Ahn JC; Buryska S; Mehta TI; Stefanescu H; Horhat A; Bumbu A; Dunn W; Attar B; Agrawal R; Haque ZS; Majeed M; Cabezas J; García-Carrera I; Parker R; Cuyàs B; Poca M; Soriano G; Sarin SK; Maiwall R; Jalal PK; Abdulsada S; Higuera-de la Tijera MF; Kulkarni AV; Rao PN; Guerra Salazar P; Skladaný L; Bystrianska N; Prado V; Clemente-Sanchez A; Rincón D; Haider T; Chacko KR; Cairo F; de Sousa Coelho M; Romero GA; Pollarsky FD; Restrepo JC; Castro-Sanchez S; Toro LG; Yaquich P; Mendizabal M; Garrido ML; Narvaez A; Bessone F; Marcelo JS; Piombino D; Dirchwolf M; Arancibia JP; Altamirano J; Kim W; Araujo RC; Duarte-Rojo A; Vargas V; Rautou PE; Issoufaly T; Zamarripa F; Torre A; Lucey MR; Mathurin P; Louvet A; García-Tsao G; González JA; Verna E; Brown RS; Roblero JP; Abraldes JG; Arrese M; Shah VH; Kamath PS; Singal AK; Bataller R
    J Hepatol; 2021 Nov; 75(5):1026-1033. PubMed ID: 34166722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In severe alcohol-related hepatitis, acute kidney injury is prevalent, associated with mortality independent of liver disease severity, and can be predicted using IL-8 and micro-RNAs.
    Tyson LD; Atkinson S; Hunter RW; Allison M; Austin A; Dear JW; Forrest E; Liu T; Lord E; Masson S; Nunes J; Richardson P; Ryder SD; Wright M; Thursz M; Vergis N
    Aliment Pharmacol Ther; 2023 Dec; 58(11-12):1217-1229. PubMed ID: 37781965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized trial of anakinra plus zinc vs. prednisone for severe alcohol-associated hepatitis.
    Gawrieh S; Dasarathy S; Tu W; Kamath PS; Chalasani NP; McClain CJ; Bataller R; Szabo G; Tang Q; Radaeva S; Barton B; Nagy LE; Shah VH; Sanyal AJ; Mitchell MC;
    J Hepatol; 2024 May; 80(5):684-693. PubMed ID: 38342441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic review with meta-analysis: high mortality in patients with non-severe alcoholic hepatitis.
    Bennett K; Enki DG; Thursz M; Cramp ME; Dhanda AD
    Aliment Pharmacol Ther; 2019 Aug; 50(3):249-257. PubMed ID: 31231848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence, clinical characteristics, and risk factors associated with recurrent alcohol-associated hepatitis.
    Patidar KR; Guarnizo Ortiz M; Slaven JE; Nephew LD; Vilar Gomez E; Kettler CD; Ghabril MS; Desai AP; Orman ES; Chalasani N; Gawrieh S
    Hepatol Commun; 2023 Dec; 7(12):. PubMed ID: 38055648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Letter: NSBB for fatty liver disease-Still a long way to go.
    Xu H; Zhang Y; Zhang J
    Aliment Pharmacol Ther; 2023 Oct; 58(8):847. PubMed ID: 37768286
    [No Abstract]   [Full Text] [Related]  

  • 12. The impact of infections on the onset of contrast-associated acute kidney injury in patients with cirrhosis.
    Tergast TL; Maasoumy B
    J Hepatol; 2024 May; 80(5):e226-e227. PubMed ID: 38181825
    [No Abstract]   [Full Text] [Related]  

  • 13. Beneficial and harmful effects of nonselective beta blockade on acute kidney injury in liver transplant candidates.
    Kim SG; Larson JJ; Lee JS; Therneau TM; Kim WR
    Liver Transpl; 2017 Jun; 23(6):733-740. PubMed ID: 28187503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-blockers and renal function.
    Wilkinson R
    Drugs; 1982 Mar; 23(3):195-206. PubMed ID: 6122552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites.
    Angeli P; Gines P; Wong F; Bernardi M; Boyer TD; Gerbes A; Moreau R; Jalan R; Sarin SK; Piano S; Moore K; Lee SS; Durand F; Salerno F; Caraceni P; Kim WR; Arroyo V; Garcia-Tsao G;
    Gut; 2015 Apr; 64(4):531-7. PubMed ID: 25631669
    [No Abstract]   [Full Text] [Related]  

  • 16. Angiotensin II receptor blocker prevents upper gastrointestinal bleeding in hypertensive patients with chronic kidney disease not on dialysis.
    Chou CY; Wang SM; Chang PH; Kuo HL; Chang CT; Liu JH; Wang IK; Yang YF; Liang CC; Huang CC
    Int J Clin Pract; 2015 Jul; 69(7):722-8. PubMed ID: 25651030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: A randomized trial.
    Cavallin M; Kamath PS; Merli M; Fasolato S; Toniutto P; Salerno F; Bernardi M; Romanelli RG; Colletta C; Salinas F; Di Giacomo A; Ridola L; Fornasiere E; Caraceni P; Morando F; Piano S; Gatta A; Angeli P;
    Hepatology; 2015 Aug; 62(2):567-74. PubMed ID: 25644760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of postoperative acute kidney injury on clinical outcomes after transcatheter aortic valve implantation: A meta-analysis of 5,971 patients.
    Gargiulo G; Sannino A; Capodanno D; Perrino C; Capranzano P; Barbanti M; Stabile E; Trimarco B; Tamburino C; Esposito G
    Catheter Cardiovasc Interv; 2015 Sep; 86(3):518-27. PubMed ID: 25641565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis of preeclampsia.
    Sircar M; Thadhani R; Karumanchi SA
    Curr Opin Nephrol Hypertens; 2015 Mar; 24(2):131-8. PubMed ID: 25636145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous venovenous hemofiltration using a stand-alone blood pump for acute kidney injury in field hospitals in Syria.
    Rifai AO; Murad LB; Sekkarie MA; Al-Makki AA; Zanabli AR; Kayal AA; Soudan KA
    Kidney Int; 2015 Feb; 87(2):254-61. PubMed ID: 25635714
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.